Generation Bio Q2 EPS $(0.31) Misses $(0.28) Estimate, Sales $4.09M Beat $1.96M Estimate
Portfolio Pulse from Benzinga Newsdesk
Generation Bio (NASDAQ:GBIO) reported Q2 EPS of $(0.31), missing the $(0.28) estimate, but sales of $4.09M beat the $1.96M estimate. EPS improved by 34.04% YoY, and sales increased by 364.89% YoY.
August 07, 2024 | 8:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Generation Bio reported a Q2 EPS of $(0.31), missing the $(0.28) estimate, but sales of $4.09M beat the $1.96M estimate. EPS improved by 34.04% YoY, and sales increased by 364.89% YoY.
Despite missing EPS estimates, Generation Bio showed significant improvement in EPS YoY and a substantial increase in sales, which could positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100